Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. - Wikidata - wikimedia - TriplyDB

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

http://www.wikidata.org/entity/Q37076713

about

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer Identification of five serum protein markers for detection of ovarian cancer by antibody arrays DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.Use of a single-chain antibody library for ovarian cancer biomarker discovery.Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.HE4 as a biomarker for ovarian and endometrial cancer management.Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Potential role of HE4 in multimodal screening for epithelial ovarian cancer Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.Early detection biomarkers for ovarian cancer.Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer.Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management.Soluble markers for diagnosis of malignant pleural mesothelioma.The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.Detection of Human Epididymis Protein 4 (HE4) in Human Serum Samples Using a Specific Monoclonal Antibody-Based Sandwich Enzyme-Linked Immunosorbent Assay (ELISA).The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.Serum concentrations of HE4 change little during in vitro fertilization.The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer.Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer.Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.

P2860

Q24651331-F7078AAD-7815-4E25-A855-B1FA9D15E2EE Q26992102-08B12540-63BF-4B05-899C-CEE9424F24AB Q28478197-3BA9996D-9BF4-4E64-88E2-498CCBCFEDC2 Q28534203-24302D1D-646E-44AB-85DE-85ABA14CBD41 Q33533746-1D898C77-9F42-46A4-95CA-B2B5720140DF Q33577786-8FD47E7A-6E5E-41C5-8F52-65EFFB2EC93F Q33623718-4065F4F8-F39A-4102-B25C-6F6819CAEBEB Q33653799-A4757BF6-4D96-4222-9106-5BC02DFE9850 Q33773348-77F1BE8E-C72D-4BA0-8425-63CE1787F141 Q34611530-FFA60ABA-D880-4EC3-8065-CD454F3F7277 Q34627854-7691672B-EE17-4D5A-BF7C-7BBEC6BF3172 Q34989820-0ECDFEE7-CC0A-41FC-A627-660F532504B8 Q35021181-C48F8A29-5DDC-4EB9-964E-B20403DB1E61 Q35499974-47167723-19EA-42C7-9529-7AF2678A4226 Q35663640-1F48A694-2370-4277-8F46-C4A761E527C6 Q35830931-7302ADC5-8634-4705-BCDB-E16F67E1286A Q36226142-0AB52F8A-99E8-4329-A796-947513E92152 Q36385490-FBF85F0B-0ACB-4035-ACAB-D945BB01A75A Q36520143-D6498A15-9A94-49D3-AC8E-FD54832D4735 Q36808757-BD847A28-7D74-47B3-9982-A1B25733A7EF Q37001660-DB935208-4A1F-47ED-8E80-9B5A8E8D5972 Q37188163-ED0D1C22-3BBE-4B6D-BCF8-1800D8AECEEC Q37270601-6DAEAF85-72B0-4D79-9648-19178B81C947 Q37329916-3F2B1A1C-A933-44D2-A04B-6A12C610D234 Q37375504-63326D3A-64E9-4FAE-A7CD-174925C57FE4 Q37703442-77E22618-5AC1-4503-9A24-1321E1C520B6 Q37713640-A5A9879D-96C8-4F73-8857-F7CA6155CF6A Q37760524-8AF5D4D3-F983-4C59-9082-E6AC1F09482C Q37862752-A91E6FA1-F36C-4234-8573-E0A37F1E828B Q38704727-32F8A31E-DA82-47EB-AED7-0081A376B59A Q38811840-C469BE63-67F5-4F27-B051-6147A59CBFB9 Q38905495-7DF84DAC-1FBB-462D-83FD-C3323ECF4E83 Q38991579-B63070C9-A46E-4081-88FF-A54CD548F646 Q48324030-1BA9771F-D617-4EBC-8F26-F31593F6EE3D Q50698085-67B52D4C-1D4F-47F2-940F-1552280E5D85 Q51082273-B6952C3C-B429-4477-B7C8-5DB684D06611 Q51206145-CDA206FC-1682-4D12-809A-2917C293D504 Q51603232-04015B95-3473-4A00-9342-2EE336682ADB Q53411263-5A06064A-D7CC-4CDC-9D07-3C51C956221E Q54678404-0583464A-5F9E-46CB-8415-7DD3259F1F51

P2860

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

http://www.wikidata.org/entity/Q37076713

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of personal characteri ...... high-risk for ovarian cancer.

@en

Effects of personal characteri ...... high-risk for ovarian cancer.

@nl

type

label

Effects of personal characteri ...... high-risk for ovarian cancer.

@en

Effects of personal characteri ...... high-risk for ovarian cancer.

@nl

prefLabel

Effects of personal characteri ...... high-risk for ovarian cancer.

@en

Effects of personal characteri ...... high-risk for ovarian cancer.

@nl

P1433

Q37076713-8AB13975-214E-4B51-B1FE-358D37B1E3D3

P1476

Q37076713-21370A08-B7DE-4B14-AA59-E68EA8DEB31F

P2093

Q37076713-09102470-24EA-437F-AC40-8B5E725D1EE1

Q37076713-2367F7AF-91AB-408C-A59D-2901D43C13F5

Q37076713-28654BA2-31F4-406C-B2A7-37342993E9DB

Q37076713-2DCFC327-5E4A-418D-B414-EEC1DFA6BDCA

Q37076713-36B1BFB7-28FF-42F2-A586-6506FE04F969

Q37076713-5133269F-B639-4767-B7F7-E6201ECDB04D

Q37076713-5D845CC3-350D-422C-953F-5BEB6AB6077D

Q37076713-71DE9F69-B11D-4D02-8059-3BB7CBA906C2

Q37076713-77471A6E-6D0E-44EE-A90A-6177452A8E66

Q37076713-7C451830-DD5D-453F-BD66-671E431EC7FB

P2860

Q37076713-0A48C1F0-4EF8-469A-88D8-F985EDFCB962

Q37076713-0AE22234-68C3-4F37-8D43-48F8DB75255F

Q37076713-2393847E-EAF3-448C-82DB-E1FDBC9BE150

Q37076713-2523D1FF-70E1-4699-A697-CD77137B2A36

Q37076713-2662A17C-3014-480B-8D72-B67B2AD3B357

Q37076713-285A4238-0382-4010-807B-A52C1E641F50

Q37076713-3C1D3783-9A06-44D1-AF58-A018CF927833

Q37076713-481037C7-0053-4977-BF6D-74706FD3D59B

Q37076713-539DC3E4-213F-4906-932B-8253CC97426F

Q37076713-64367AB9-F1B6-410E-941B-573F18D61872

P304

Q37076713-C490E83B-7487-48E2-8711-49807708D960

P31

Q37076713-7A237476-0B89-471F-9B72-C1BA679F3CA5

P356

Q37076713-4E2CB391-9707-4C9D-90EA-71A30FFC6554

P433

Q37076713-5591136E-A4C8-43E5-BB0E-DA928CCAE06D

P478

Q37076713-B848D04B-5A8A-405D-B627-7AB05B8E096F

P577

Q37076713-1AAA4E4E-64E1-498B-B8B7-EBF9E00C35BA

P698

Q37076713-A58E445D-8A24-4510-9355-A519B974136F

P921

Q37076713-C476BC97-3177-4598-81E7-0227DF53BEBE

P932

Q37076713-05770C3D-73C2-445D-AEBA-E31443765081

P356

1055-9965.EPI-08-0150

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Effects of personal characteri ...... high-risk for ovarian cancer.

@en

P2093

Charles W Drescher

http://www.w3.org/2001/XMLSchema#string

Chirag Shah

http://www.w3.org/2001/XMLSchema#string

Erin Wallace

http://www.w3.org/2001/XMLSchema#string

Garnet Anderson

http://www.w3.org/2001/XMLSchema#string

Jason Thorpe

http://www.w3.org/2001/XMLSchema#string

Kimberly A Lowe

http://www.w3.org/2001/XMLSchema#string

Lindsay Bergan

http://www.w3.org/2001/XMLSchema#string

M Robyn Andersen

http://www.w3.org/2001/XMLSchema#string

Martin McIntosh

http://www.w3.org/2001/XMLSchema#string

Nathalie Scholler

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

CA 125: the past and the future.

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

Ovarian cancer: epidemiology, biology, and prognostic factors.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Potential markers that complement expression of CA125 in epithelial ovarian cancer.

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

New tumor markers: CA125 and beyond.

P304

2480-2487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-08-0150

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18768519

http://www.w3.org/2001/XMLSchema#string

P921

P932

2632599

http://www.w3.org/2001/XMLSchema#string